Identified metabolic signature for assessing red blood cell unit quality is associated with endothelial damage markers and clinical outcomes

Transfusion

Volumn 56, Issue 4, 2016, Pages 852-862

  Bordbar, Aarash ^a   Johansson, Pär I ^b   Paglia, Giuseppe ^c   Harrison, Scott J ^d   Wichuk, Kristine ^c   Magnusdottir, Manuela ^c   Valgeirsdottir, Sóley ^c   Gybel Brask, Mikkel ^b   Ostrowski, Sisse R ^b   Palsson, Sirus ^a,c   Rolfsson, Ottar ^c   Sigurjónsson, Olafur E ^e,f   Hansen, Morten B ^b   Gudmundsson, Sveinn ^e   Palsson, Bernhard O ^c  

^a Sinopia Biosciences   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF ICELAND   (Iceland)

^d Chalmers University of Technology   (Denmark)

^e LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^f REYKJAVIK UNIVERSITY   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; FRUCTOSE 6 PHOSPHATE; GLUTAMINE; INOSINE PHOSPHATE; PROLINE; S ADENOSYLMETHIONINE; SERINE; SYNDECAN 1; THROMBOMODULIN; URIC ACID; VALINE; VASCULAR ENDOTHELIAL CADHERIN; BIOLOGICAL MARKER;

ARTICLE; AUTOLOGOUS TRANSFUSION; AUTOTRANSPLANTATION; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; HEART RATE; HEMOLYSIS; HUMAN; HYDROPHILIC INTERACTION CHROMATOGRAPHY; MALE; METABOLOMICS; NEAR INFRARED SPECTROSCOPY; NORMAL HUMAN; OBSERVATIONAL STUDY; PH; SYSTEMS BIOLOGY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; BLOOD; BLOOD STORAGE; CYTOLOGY; DENMARK; ICELAND; METABOLISM; METABOLOME; PATHOLOGY; PROCEDURES; QUALITY CONTROL; STANDARDS; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

BIOMARKERS; BLOOD PRESERVATION; DENMARK; ENDOTHELIUM, VASCULAR; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HEALTHY VOLUNTEERS; HUMANS; ICELAND; MALE; METABOLOME; METABOLOMICS; QUALITY CONTROL; TREATMENT OUTCOME;

EID: 84963543358     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13460     Document Type: Article

References (57)

1. Takei T, Amin NA, Schmid G, et al., Progress in global blood safety for HIV. J Acquir Immune Defic Syndr 2009; 52 Suppl 2: S127-31.
2. Zimring, JC., Established and theoretical factors to consider in assessing the red cell storage lesion. Blood 2015; 125: 2185-90.
3. Hess JR., Red cell changes during storage. Transfus Apher Sci 2010; 43: 51-9.
4. Koch CG, Li L, Sessler DI, et al., Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358: 1229-39.
5. Wang D, Sun J, Solomon SB, et al., Transfusion of older stored blood and risk of death: a meta-analysis. Transfusion 2012; 52: 1184-95.
6. Spinella PC, Carroll CL, Staff I, et al., Duration of red blood cell storage is associated with increased incidence of deep vein thrombosis and in hospital mortality in patients with traumatic injuries. Crit Care 2009; 13: R151.
7. Lee JS, Gladwin MT., Bad blood: the risks of red cell storage. Nat Med 2010; 16: 381-2.
8. Larsen AM, Leinøe EB, Johansson PI, et al., Haemostatic function and biomarkers of endothelial damage before and after RBC transfusion in patients with haematologic disease. Vox Sang 2015; 109: 52-61.
9. Neuman R, Hayek S, Rahman A, et al., Effects of storage-aged red blood cell transfusions on endothelial function in hospitalized patients. Transfusion 2015 2015; 55: 782-90.
10. Lacroix, J, Hébert PC, Fergusson DA, et al., Age of transfused blood in critically ill adults. N Engl J Med 2015; 372: 1410-8.
11. Steiner ME, Ness PM, Assmann SF, et al., Effects of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med 2015; 372: 1419-29.
12. Fergusson DA, Hébert P, Hogan DL, et al., Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial. JAMA 2012; 308: 1443-51.
13. Kinnunen, EM, Sabatelli L, Juvonen T, et al., Red blood cell storage time and the outcome after coronary surgery. J Surg Res 2015; 197: 58-64.
14. van Straten AH, Soliman Hamad MA, van Zundert AA, et al., Effect of duration of red blood cell storage on early and late mortality after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2011; 141: 231-7.
15. Weinberg JA, McGwin G Jr, Griffin RL, et al., Age of transfused blood: an independent predictor of mortality despite universal leukoreduction. J Trauma 2008; 65: 279-82; discussion 282-4.
16. van de Watering L, Lorinser J, Versteegh M, et al., Effects of storage time of red blood cell transfusions on the prognosis of coronary artery bypass graft patients. Transfusion 2006; 46: 1712-8.
17. Robinson SD, Janssen C, Fretz EB, et al., Red blood cell storage duration and mortality in patients undergoing percutaneous coronary intervention. Am Heart J 2010; 159: 876-81.
18. Edgren G, Kamper-Jørgensen M, Eloranta S, et al., Duration of red blood cell storage and survival of transfused patients (CME). Transfusion 2010; 50: 1185-95.
19. Demidenko E., Sample size determination for logistic regression revisited. Stat Med 2007; 26: 3385-97.
20. Lacroix J, Hébert P, Fergusson D, et al., The age of blood evaluation (ABLE) randomized controlled trial: study design. Transfus Med Rev 2011; 25: 197-205.
21. Steiner ME, Assmann SF, Levy JH, et al., Addressing the question of the effect of RBC storage on clinical outcomes: the Red Cell Storage Duration Study (RECESS) (Section 7). Transfus Apher Sci 2010; 43: 107-16.
22. Paglia G, Sigurjónsson ÓE, Rolfsson Ó, et al., Metabolomic analysis of platelets during storage: a comparison between apheresis- and buffy coat-derived platelet concentrates. Transfusion 2015; 55: 301-13.
23. Paglia G, Sigurjónsson ÓE, Rolfsson Ó, et al., Comprehensive metabolomic study of platelets reveals the expression of discrete metabolic phenotypes during storage. Transfusion 2014; 54: 2911-23.
24. Orth JD, Thiele I, Palsson BO., What is flux balance analysis? Nat Biotechnol 2010; 28: 245-8.
25. Lewis NE, Nagarajan H, Palsson BO., Constraining the metabolic genotype-phenotype relationship using a phylogeny of in silico methods. Nat Rev Microbiol 2012; 10: 291-305.
26. Bordbar A, Monk JM, King ZA, et al., Constraint-based models predict metabolic and associated cellular functions. Nat Rev Genet 2014; 15: 107-20.
27. Bordbar A, Jamshidi N, Palsson BO., iAB-RBC-283: a proteomically derived knowledge-base of erythrocyte metabolism that can be used to simulate its physiological and patho-physiological states. BMC Syst Biol 2011; 5: 110.
28. Schellenberger J, Que R, Fleming RM, et al., Quantitative prediction of cellular metabolism with constraint-based models: the COBRA toolbox v2.0. Nat Protoc 2011; 6: 1290-307.
29. Edgren G, Rostgaard K, Vasan SK, et al., The new Scandinavian Donations and Transfusions Database (SCANDAT2): a blood safety resource with added versatility. Transfusion 2015; 55: 1600-6.
30. Gevi F, D'Alessandro A, Rinalducci S, et al., Alterations of red blood cell metabolome during cold liquid storage of erythrocyte concentrates in CPD-SAGM. J Proteomics 2012; 76: 168-80.
31. Roback JD, Josephson CD, Waller EK, et al., Metabolomics of ADSOL (AS-1) red blood cell storage. Transfus Med Rev 2014; 28: 41-55.
32. D'Alessandro A, Nemkov T, Kelher M, et al., Routine storage of red blood cell (RBC) units in additive solution-3: a comprehensive investigation of the RBC metabolome. Transfusion 2015; 55: 1155-68.
33. Pitt JJ, Hauser S., Transient 5-oxoprolinuria and high anion gap metabolic acidosis: clinical and biochemical findings in eleven subjects. Clin Chem 1998; 44: 1497-503.
34. Mo ML, Palsson BO, Herrgard MJ., Connecting extracellular metabolomic measurements to intracellular flux states in yeast. BMC Syst Biol 2009; 3: 37.
35. van de Watering L., Pitfalls in the current published observational literature on the effects of red blood cell storage. Transfusion 2011; 51: 1847-54.
36. Johansen ME, Johansson PI, Ostrowski SR, et al., Profound endothelial damage predicts impending organ failure and death in sepsis. Semin Thromb Hemost 2015; 41: 16-25.
37. Johansson PI, Stensballe J, Rasmussen LS, et al., A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg 2011; 254: 194-200.
38. Ostrowski SR, Pedersen SH, Jensen JS, et al., Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines. Crit Care 2013; 17: R32.
39. Johansson PI, Bro-Jeppesen J, Kjaergaard J, et al., Sympathoadrenal activation and endothelial damage are inter correlated and predict increased mortality in patients resuscitated after out-of-hospital cardiac arrest. A post hoc sub-study of patients from the TTM-trial. PLoS One 2015; 10: e0120914.
40. Nolte D, Zeintl H, Steinbauer M, et al., Functional capillary density: an indicator of tissue perfusion? Int J Microcirc Clin Exp 1995; 15: 244-9.
41. Creteur J, Neves AP, Vincent JL., Near-infrared spectroscopy technique to evaluate the effects of red blood cell transfusion on tissue oxygenation. Crit Care 2009; 13: S11.
42. Ikegami K, Suzuki Y, Yukioka T, et al., Endothelial cell injury, as quantified by the soluble thrombomodulin level, predicts sepsis/multiple organ dysfunction syndrome after blunt trauma. J Trauma 1998; 44: 789-94. discussion 794-5.
43. Ayhan B, Yuruk K, Koene S, et al., The effects of non-leukoreduced red blood cell transfusions on microcirculation in mixed surgical patients. Transfus Apher Sci 2013; 49: 212-22.
44. Monahan J., Violence in the workplace. J Occup Med 1990; 32: 1021.
45. Kaya M, Moriwaki Y, Ka T, et al., Plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine) and oxypurinol after rigorous exercise. Metabolism 2006; 55: 103-7.
46. Jabs CM, Sigurdsson GH, Neglen P,. Plasma levels of high-energy compounds compared with severity of illness in critically ill patients in the intensive care unit. Surgery 1998; 124: 65-72.
47. Niwa T, Takeda N, Yoshizumi H., RNA metabolism in uremic patients: accumulation of modified ribonucleosides in uremic serum. Technical note. Kidney Int 1998; 53: 1801-6.
48. Tavazzi B, Lazzarino G, Leone P, et al., Simultaneous high performance liquid chromatographic separation of purines, pyrimidines, N-acetylated amino acids, and dicarboxylic acids for the chemical diagnosis of inborn errors of metabolism. Clin Biochem 2005; 38: 997-1008.
49. Simmonds, HA, Reiter S, Nishino T., Hereditary xanthinuria. In:, Scriver CR, Beaudet AL, Sly WS, et al., editors. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill; 1995. p. 1781-98.
50. Eells JT, Spector R., Purine and pyrimidine base and nucleoside concentrations in human cerebrospinal fluid and plasma. Neurochem Res 1983; 8: 1451-7.
51. Zhu Y, Pandya BJ, Choi HK., Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011; 63: 3136-41.
52. Pastore A, Massoud R, Motti C, et al., Fully automated assay for total homocysteine, cysteine, cysteinylglycine, glutathione, cysteamine, and 2-mercaptopropionylglycine in plasma and urine. Clin Chem 1998; 44: 825-32.
53. McGregor DO, Dellow WJ, Lever M, et al., Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations. Kidney Int 2001; 59: 2267-72.
54. Friesen RW, Novak EM, Hasman D, et al., Relationship of dimethylglycine, choline, and betaine with oxoproline in plasma of pregnant women and their newborn infants. J Nutr 2007; 137: 2641-6.
55. Larsson A, Zetterström R, Hagenfeldt L, et al., Pyroglutamic aciduria (5-oxoprolinuria), an inborn error in glutathione metabolism. Pediatr Res 1974; 8: 852-6.
56. Cynober LA., Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition 2002; 18: 761-6.
57. Psychogios N, Hau DD, Peng J, et al., The human serum metabolome. PLoS One 2011; 6: e16957.